MOLECULAR DETERMINANTS OF HIV EXPRESSION BY OPIATES
MOLECULAR DETERMINANTS OF HIV EXPRESSION BY OPIATES
批准号:
3213118
负责人:
OM PRAKASH
金额:
$18.48万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-08-01 至 1992-07-31
关键词:
HIV infections T lymphocyte acyltransferase antisense nucleic acid autoradiography brain clone cells drug abuse fusion gene gene deletion mutation gene expression genetic manipulation genetic regulatory element genetic transcription genetically modified animals genome hematopoietic tissue human immunodeficiency virus human tissue laboratory mouse morphine naloxone neurons nucleic acid repetitive sequence nucleoproteins opiate alkaloid protooncogene tissue /cell culture transfection
中文摘要
逆转录病毒HIV(人类免疫缺陷病毒)已被确认为
获得性免疫缺陷综合症(艾滋病)的病原体。
在许多情况下,感染之后会出现临床上的静止期或潜伏期
只要宿主的抗病毒防御是持续的,这个阶段就会持续
完好无损。这些发现增加了宿主易感性的可能性
因素(即“环境辅助因素”)可能会影响进程。
这种疾病的危害。显然,对这种辅因的识别是
对理解和描述这一现象具有重大意义
艾滋病的发病机制。据估计,美国25%的艾滋病病例
各州都是吸毒者。最近,有研究发现,各种“毒品”
滥用“(即阿片类药物)具有免疫调节作用和免疫损害作用。
对鸦片类药物可作为推定的环境保护物质的建议
影响HIV易感性和进展的辅助因素
感染。我们的目标是定义鸦片类药物和
人类免疫缺陷病毒基因组的功能水平。我们会
使用分子遗传学方法以及在体外和活体模型中
表征阿片类药物对转录调控的影响
爱滋病毒。为了直接检查这个问题,我们将使用HIV-Long终端
重复-氯霉素乙酰转移酶融合基因(HIV/LTR-CAT)。
HIV/LTR-CAT嵌合构建物将被导入两个人
克隆性T细胞与人类神经细胞的关系
在体外模型中,以检查这种假定的关系。我们有
证明了OTH细胞类型对吗啡的反应
纳洛酮-可逆方式在基因表达水平。我们将使用
用于确定HIV阿片剂反应区的缺失突变
Ltr.因为我们实验室以前的结果证明了
吗啡对c-fos基因表达的快速短暂诱导作用
还将确定Fos是否可以作为适配器基因并将
阿片类药物对HIV激活的短期受体后效应
表情。我们的假设是基于最近发现的两个
HIV LTR中的AP-1转录调控序列以及
AP-1序列是转录激活所必需的
通过含有Fos的核蛋白复合体获得真核基因。最后,我们
已提出将HIV/LTR-CAT融合基因引入猪的种系
小鼠(即转基因小鼠),以便在体内建立适当的
模特们。我们预测,我们的发现将对
艾滋病的发病机制被归类为吸毒者。
英文摘要
The retrovirus HIV (human immunodeficiency virus) has been identified as
the causative agent in acquired immunodeficiency syndrome (AIDS).
Infection is followed in many cases by a clinically quiescent or latent
phase that appears to continue as long as host antiviral defense is
intact. These findings raise the possibility htat host susceptibility
factors (i.e., "environmental cofactors") may influence the progression
of the disease. The identification of such cofactors is, obviously, of
immense significance in the understanding and characterization of the
pathogenesis of AIDS. An estimated 25% of all AIDS cases in the United
States are drug abusers. Recently, the findings that various "drugs of
abuse" (i.e., opiates) are immunomodulatory and immunocompromising has
ld to the suggestion that opiates may serve as putative environmntal
cofactors and influence the susceptibility and progression of HIV
infection. Our goal is to define the relationship between opiates and
the human immunodeficiency virus genome on a functional level. We will
use molecular genetic approaches and both in vitro and in vivomodels to
characterize the effects of opiates on the transcriptional regulation of
HIV. To examine this question directly, we will use HIV-long terminal
repeat-chloramphenicol acetyltransferase fusion genes (HIV/LTR-CAT).
The HIV/LTR-CAT chimeric constructs will be transfected into both human
clonal T-cells and human neural cells in order to establish appropriate
in vitro models in which to examine this putative relationship. W have
demonstrated that obth cell types are responsive to morphine in a
naloxone-reversible manner at the level of gene expression. We will use
deletion mutagenesis to define the opiate-responsive region of the HIV
LTR. Since previous results from our laboratory have demonstrated a
rapid and transient inductive effect of morphine on c-fos expression, we
will also determine if Fos can function as an adaptor gene and link the
short-term post-receptor effects of opiates to the activation HIV
expression. Our hypothesis is based on the recent identification of two
AP-1 transcriptional regulatory sequences within the HIV LTR and that
the AP-1 sequence is required for the transcriptional activation of
eukaryotic genes by a Fos-containing nucleoprotein complex. Finally, we
have proposed to introduce HIV/LTR-CAT fusion genes into the germline of
mice (i.e., transgenic mice) in order to establish appropriate in vivo
models. We predict our findings will have important implications for
the pathogenesis of AIDS in patients classified as drug abusers.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity.
TAT72 转基因小鼠的免疫学特征:吗啡对细胞介导的免疫的影响。
DOI:
10.1016/0192-0561(94)90086-8
发表时间:
1994
期刊:
International journal of immunopharmacology
影响因子:
--
作者:
[GarzaJr,HH, Prakash,O, Carr,DJ]
通讯作者:
Carr,DJ
DOI:
10.1089/aid.1990.6.1163
发表时间:
1990-10
期刊:
AIDS research and human retroviruses
影响因子:
1.5
作者:
[S. Squinto;D. Mondal;A. L. Block;O. Prakash]
通讯作者:
S. Squinto;D. Mondal;A. L. Block;O. Prakash
ACQUISITION OF A 500MHZ HIGH-RESOLUTION NMR CRYOPROBE
-
批准号:7335135
-
项目类别:
-
资助金额:$14.1万
-
财政年份:2006
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL EFFECT OF AZT PHOSPHORYLATION REQUIRED FOR ACTIVATION OF AZT
-
批准号:6652164
-
项目类别:
-
资助金额:$13.07万
-
财政年份:2002
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL EFFECT OF AZT PHOSPHORYLATION REQUIRED FOR ACTIVATION OF AZT
-
批准号:6563176
-
项目类别:
-
资助金额:$13.07万
-
财政年份:2001
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL EFFECT OF AZT PHOSPHORYLATION REQUIRED FOR ACTIVATION OF AZT
-
批准号:6409984
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2000
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL EFFECT OF AZT PHOSPHORYLATION REQUIRED FOR ACTIVATION OF AZT
-
批准号:6218632
-
项目类别:
-
资助金额:$19.78万
-
财政年份:1999
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL EFFECT OF AZT PHOSPHORYLATION REQUIRED FOR ACTIVATION OF AZT
-
批准号:6097709
-
项目类别:
-
资助金额:$19.78万
-
财政年份:1999
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL EFFECT OF AZT PHOSPHORYLATION REQUIRED FOR ACTIVATION OF AZT
-
批准号:6345865
-
项目类别:
-
资助金额:$18.46万
-
财政年份:1999
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL EFFECT OF AZT PHOSPHORYLATION REQUIRED FOR ACTIVATION OF AZT
-
批准号:6299182
-
项目类别:
-
资助金额:$19.78万
-
财政年份:1999
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL, HIV1 PROTEINS AND IMMUNOSUPPRESSION
-
批准号:2563856
-
项目类别:
-
资助金额:$9.36万
-
财政年份:1997
-
负责人:OM PRAKASH
-
依托单位:
ALCOHOL, HIV1 PROTEINS AND IMMUNOSUPPRESSION
-
批准号:2769240
-
项目类别:
-
资助金额:$9.31万
-
财政年份:1997
-
负责人:OM PRAKASH
-
依托单位:
MOLECULAR DETERMINANTS OF HIV EXPRESSION BY OPIATES
-
批准号:3213117
-
项目类别:
-
资助金额:$17.53万
-
财政年份:1989
-
负责人:OM PRAKASH
-
依托单位:
MOLECULAR DETERMINANTS OF HIV EXPRESSION BY OPIATES
-
批准号:3213116
-
项目类别:
-
资助金额:$16.38万
-
财政年份:1989
-
负责人:OM PRAKASH
-
依托单位:
海外基金